1. Barlozzari, T., Leonhardt, J., Wiltrout, R. H., Herberman, R. B., andReynolds, C. W., 1985, Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.Journal of Immunology,134, 2783–2789.
2. Djeu, J. Y., Heinbaugh, J. A., Holden, H. T., andHerberman, R. B., 1979, Augmentation of mouse natural killer cell activity by interferon and interferon inducers.Journal of Immunology,122, 175–181.
3. Eisenthal, A., Cameron, R. B., Uppenkamp, I., andRosenberg, S. A., 1988, Effect of combined therapy with lymphokine-activated killer cells, interleukin-2 and specific monoclonal antibody on established melanoma lung metastases.Cancer Research,48, 7140–7145.
4. Fidler, I. J., Darnell, J. H., andBudmen, M. B., 1976, Tumoricidal properties of macrophages activated with mediators from rat lymphocytes stimulated with concanavalin A,Cancer Research,36, 3608–3615.
5. Gidland, M. A., Orn, A., Wigzell, H., Senik, A., andGresser, I., 1978, Enhanced NK cell activity in mice injected with interferon and interferon inducers.Nature,273, 759–761.